Restylane Skinboosters Vital Dosage/Direction for Use

Needle: Disposable sterile 29G TW needles are provided. Alternatively, a sterile blunt cannula 30G can be used. The size and the length of the cannula will affect the force needed to extrude the gel. If a thinner cannula is used the resistance during injection may be too high resulting in an increased risk for leakage or separation of the cannula and syringe. The same considerations are applicable for needles.
Assembly of needle to syringe: Use the thumb and forefinger to hold firmly around both the glass syringe and the luer-lock adapter. Grasp the needle shield (or hub if using cannula) with the other hand. To facilitate proper fastening, both push and rotate firmly. Strict aseptic technique must be followed.
Improper assembly may result in separation of the needle and syringe during injection.
Treatment procedure: The patient shall be informed about the indications, expected result, precautions and potential adverse events. The patient's need for pain relief should be assessed.
Clean the treatment site thoroughly with a suitable antiseptic solution.
To avoid breakage of the needle or cannula, do not attempt to bend or otherwise manipulate it before or during treatment.
The Smart Click System is activated by pressing down the button located on the finger grip until it locks into place.
Before injecting, remove the air by pressing the rod carefully until a small droplet is visible at the tip of the needle. When the Smart Click System is switched on, press the plunger rod carefully until the first click is heard to prime the system before use.
As an alternative to the needle, a blunt cannula can be used. After preparation as previously described, an entry point is made in the skin, e.g. with a sharp needle of appropriate size. Inject slowly. During injection, keep the side hole of the cannula facing downwards, away from the skin surface, to ensure that the flow of the gel is maintained at the correct tissue depth.
Do not apply excessive pressure to the syringe at any time. Presence of scar tissue may impede advancement of the cannula/needle. If resistance is encountered the cannula/needle should be partially withdrawn and repositioned or fully withdrawn and checked for function.
A too large volume or a too superficial injection may give bumps on the treatment site.
Treated areas can be gently massaged immediately after the injection if any irregularities are noted.
Restylane Skinboosters Vital Lidocaine: This product should be injected in the dermal layer of the skin, preferably in the deeper part of dermis.
A treatment plan for this product with three treatments 4 weeks apart is recommended. Generally, a maintenance treatment is repeated every 6 months, but results and patient preferences may vary.
Restylane Skinboosters Vital Light Lidocaine: This product should be injected into mid dermis of the skin.
A treatment plan for this product with three treatments 2-4 weeks apart is recommended. Generally, a maintenance treatment is repeated every 4-6 months, but results and patient preferences may vary.